tiprankstipranks
Trending News
More News >
Renalytix (RENXF)
OTHER OTC:RENXF
US Market

Renalytix (RENXF) Ratios

Compare
7 Followers

Renalytix Ratios

RENXF's free cash flow for Q2 2025 was $0.55. For the 2025 fiscal year, RENXF's free cash flow was decreased by $ and operating cash flow was $-6.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.24- 0.53 1.76 3.89
Quick Ratio
0.24- 0.53 1.71 3.79
Cash Ratio
0.08- 0.41 1.53 3.39
Solvency Ratio
-0.73- -2.09 -1.91 -2.23
Operating Cash Flow Ratio
-0.97- -2.62 -2.03 -3.75
Short-Term Operating Cash Flow Coverage
-2.82- -7.24 -7.32 -9.82
Net Current Asset Value
$ -13.23M-$ -9.71M$ 4.67M$ 27.34M
Leverage Ratios
Debt-to-Assets Ratio
1.72- 1.07 0.29 0.20
Debt-to-Equity Ratio
-0.73- -1.09 0.66 0.29
Debt-to-Capital Ratio
-2.69- 12.53 0.40 0.23
Long-Term Debt-to-Capital Ratio
-0.57- -1.23 0.29 0.15
Financial Leverage Ratio
-0.42- -1.02 2.28 1.47
Debt Service Coverage Ratio
-2.29- -6.86 -9.35 -11.31
Interest Coverage Ratio
0.00- 0.00 0.00 -28.69K
Debt to Market Cap
0.37- 0.56 0.03 0.05
Interest Debt Per Share
0.16- 0.08 0.05 0.06
Net Debt to EBITDA
-0.77- -0.14 0.30 0.54
Profitability Margins
Gross Profit Margin
12.27%-6.82%20.60%30.91%
EBIT Margin
-867.96%--1261.90%-1240.70%-1790.67%
EBITDA Margin
-857.13%--1246.00%-1225.77%-1774.21%
Operating Profit Margin
-868.05%--1293.49%-1244.64%-1931.72%
Pretax Profit Margin
-1064.98%--1461.42%-1358.24%-1670.98%
Net Profit Margin
-1065.16%--1461.60%-1340.20%-1524.44%
Continuous Operations Profit Margin
-1065.16%--1461.60%-1340.20%-1524.44%
Net Income Per EBT
100.02%-100.01%98.67%91.23%
EBT Per EBIT
122.69%-112.98%109.13%86.50%
Return on Assets (ROA)
-246.18%--419.67%-108.29%-71.57%
Return on Equity (ROE)
123.11%-425.97%-247.14%-104.88%
Return on Capital Employed (ROCE)
133.23%-840.42%-163.00%-112.38%
Return on Invested Capital (ROIC)
313.75%--4348.24%-138.53%-103.03%
Return on Tangible Assets
-246.18%--419.67%-154.05%-91.95%
Earnings Yield
-107.83%--222.26%-12.95%-17.37%
Efficiency Ratios
Receivables Turnover
1.23- 3.17 4.39 3.30
Payables Turnover
0.17- 0.82 0.92 0.83
Inventory Turnover
0.00- 0.00 3.76 1.77
Fixed Asset Turnover
5.49- 10.60 2.79 0.96
Asset Turnover
0.23- 0.29 0.08 0.05
Working Capital Turnover Ratio
-0.15- 0.85 0.14 0.06
Cash Conversion Cycle
-1.80K- -331.15 -216.39 -120.33
Days of Sales Outstanding
297.14- 115.13 83.23 110.73
Days of Inventory Outstanding
0.00- 0.00 96.99 206.34
Days of Payables Outstanding
2.10K- 446.28 396.61 437.40
Operating Cycle
297.14- 115.13 180.22 317.06
Cash Flow Ratios
Operating Cash Flow Per Share
-0.22- -0.28 -0.13 -0.22
Free Cash Flow Per Share
-0.22- -0.28 -0.13 -0.23
CapEx Per Share
<0.01- <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
1.00- 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
-11.66K- -7.53K 0.00 -65.91
Capital Expenditure Coverage Ratio
-11.66K- -7.53K 0.00 -65.91
Operating Cash Flow Coverage Ratio
-1.41- -3.53 -2.69 -3.60
Operating Cash Flow to Sales Ratio
-10.53- -13.15 -9.60 -15.40
Free Cash Flow Yield
-51.73%--200.06%-9.28%-17.81%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.93- -0.45 -7.72 -5.76
Price-to-Sales (P/S) Ratio
20.35- 6.58 103.49 87.79
Price-to-Book (P/B) Ratio
-0.97- -1.92 19.08 6.04
Price-to-Free Cash Flow (P/FCF) Ratio
-1.93- -0.50 -10.78 -5.61
Price-to-Operating Cash Flow Ratio
-0.94- -0.50 -10.78 -5.70
Price-to-Earnings Growth (PEG) Ratio
-0.04- 0.01 0.68 -0.22
Price-to-Fair Value
-0.97- -1.92 19.08 6.04
Enterprise Value Multiple
-3.15- -0.66 -8.14 -4.40
Enterprise Value
29.89M- 18.91M 339.65M 232.10M
EV to EBITDA
-3.15- -0.66 -8.14 -4.40
EV to Sales
26.98- 8.26 99.81 78.15
EV to Free Cash Flow
-2.56- -0.63 -10.40 -5.00
EV to Operating Cash Flow
-2.56- -0.63 -10.40 -5.07
Tangible Book Value Per Share
-0.21- -0.07 0.07 0.14
Shareholders’ Equity Per Share
-0.21- -0.07 0.07 0.21
Tax and Other Ratios
Effective Tax Rate
>-0.01- >-0.01 >-0.01 >-0.01
Revenue Per Share
0.02- 0.02 0.01 0.01
Net Income Per Share
-0.22- -0.31 -0.18 -0.22
Tax Burden
1.00- 1.00 0.99 0.91
Interest Burden
1.23- 1.16 1.09 0.93
Research & Development to Revenue
1.79- 4.10 4.20 4.93
SG&A to Revenue
7.01- 8.63 12.65 4.36
Stock-Based Compensation to Revenue
0.61- 0.75 0.86 1.56
Income Quality
0.99- 0.90 0.71 0.92
Currency in USD